Pathogenic mechanisms of influenza A(H1N1)pdm09 infection elucidated on gene expression profiling

Pediatrics International

Volumn 55, Issue 5, 2013, Pages 572-577

  Yamashita, Nobuko ^a   Tsukahara, Hirokazu ^a   Tsuge, Mitsuru ^a   Nagaoka, Yoshiharu ^a   Yashiro, Masato ^a   Saito, Yukie ^a   Fujii, Yosuke ^a   Oka, Takashi ^a   Morishima, Tsuneo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

central nervous system manifestations; gene expression profile; influenza A(H1N1)pdm09; pneumonia

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SYNUCLEIN; AMPHIREGULIN; ARGINASE; CONTACTIN ASSOCIATED PROTEIN LIKE 3; DESMOCOLLIN 2; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN FC FRAGMENT; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 18 RECEPTOR ALPHA; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OLFACTOMEDIN 4; ONCOSTATIN M; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SCATTER FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 117;

ARTICLE; BLOOD; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CONVULSION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLUENZA A (H1N1); INNATE IMMUNITY; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL;

CENTRAL NERVOUS SYSTEM MANIFESTATIONS; GENE EXPRESSION PROFILE; INFLUENZA A(H1N1)PDM09; PNEUMONIA;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MICROARRAY ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84886093564     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12139     Document Type: Article

References (21)

1. Halasa NB,. Update on the 2009 pandemic influenza A H1N1 in children. Curr. Opin. Pediatr. 2010; 22: 83-87.
2. Calitri C, Gabiano C, Garazzino S, et al. Clinical features of hospitalised children with 2009 H1N1 influenza virus infection. Eur. J. Pediatr. 2010; 169: 1511-1515.
3. Baltagi SA, Shoykhet M, Felmet K, Kochanek PM, Bell MJ,. Neurological sequelae of 2009 influenza A (H1N1) in children: A case series observed during a pandemic. Pediatr. Crit. Care Med. 2010; 11: 179-184.
4. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D,. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010; 182: 39-44.
5. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 2010; 362: 1708-1719.
6. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: Characteristics, incidence, and risk factors. J. Pediatr. 2007; 150: 306-310. (Pubitemid 46328959)
7. Hasegawa S, Matsushige T, Inoue H, Shirabe K, Fukano R, Ichiyama T,. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 2011; 54: 167-172.
8. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit. Care 2009; 13: R201.
9. Takano T, Tajiri H, Kashiwagi Y, Kimura S, Kawashima H,. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2011; 30: 117-120.
10. Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y,. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol. Immunol. 2011; 55: 191-198.
11. Poon LL, Chan KH, Smith GJ, et al. Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. Clin. Chem. 2009; 55: 1555-1558.
12. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4: P3.
13. Kawada J, Kimura H, Kamachi Y, et al. Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. J. Gen. Virol. 2006; 87: 1677-1683. (Pubitemid 43827222)
14. Arankalle VA, Lole KS, Arya RP, et al. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS ONE 2010; 5: e13099.
15. Liu L, Li R, Pan Y, et al. High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection. Clin. Chim. Acta 2011; 412: 1081-1085.
16. Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: A mechanism for the pathogenesis of avian influenza H5N1 infection. J. Infect. Dis. 2008; 198: 525-535.
17. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M,. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol. Scand. Suppl. 2007; 186: 45-56. (Pubitemid 46376171)
18. Spiegel I, Salomon D, Erne B, Schaeren-Wiemers N, Peles E,. Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains. Mol. Cell. Neurosci. 2002; 20: 283-297. (Pubitemid 34762137)
19. Buttner P, Mosig S, Lechtermann A, Funke H, Mooren FC,. Exercise affects the gene expression profiles of human white blood cells. J. Appl. Physiol. 2007; 102: 26-36. (Pubitemid 46089748)
20. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA,. Fatty acids and lymphocyte functions. Br. J. Nutr. 2002; 87: S31-S48. (Pubitemid 34134102)
21. Schmitz N, Kurrer M, Bachmann MF, Kopf M,. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 2005; 79: 6441-6448. (Pubitemid 40617247) Technology